Identifying Adverse Events of Ofatumumab and Rituximab in the Treatment of Multiple Sclerosis Based on the FAERS Database

LI Ying, GUAN Mingyuan, DUAN Ranran, KANG Jian

Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (9) : 845-851.

PDF(1600 KB)
PDF(1600 KB)
Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (9) : 845-851. DOI: 10.11669/cpj.2024.09.011

Identifying Adverse Events of Ofatumumab and Rituximab in the Treatment of Multiple Sclerosis Based on the FAERS Database

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 59(9): 845-851 https://doi.org/10.11669/cpj.2024.09.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1600 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉